VAERS reports by lot

Moderna COVID-19 lot AS1414B: VAERS reports

468 VAERS reports list lot AS1414B as a Moderna COVID-19 vaccine, received between 2022-06-21 and 2024-03-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
468
Reports
1%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)11622%
Gastrointestinal10119%
Respiratory6412%
Injection-site / Local reaction5310%
Dermatological (non-injection-site)5110%
Cardiac / Cardiovascular408%
Allergic / Anaphylactic326%
Neurological306%
Psychiatric / Neuropsychiatric204%
Musculoskeletal102%
Thrombotic / Hematological92%
Autoimmune / Immune-mediated41%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington78
Illinois31
Colorado30
Michigan30
Virginia30
New York27
Maryland23
Massachusetts18
Connecticut14
New Jersey13
Arizona10
North Carolina9

Reports by month received

2022-0627
2022-07114
2022-08151
2022-0936
2022-109
2022-1110
2022-1260
2023-0121
2023-0214
2023-039
2023-048
2023-052
2023-061
2023-071
2023-121
2024-034

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.